OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Cardiology is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
COVID-19 and the cardiovascular system	2174
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives	921
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions	552
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective	546
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension	476
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control	353
T cell subsets and functions in atherosclerosis	352
Environmental determinants of cardiovascular disease: lessons learned from air pollution	343
Interplay between inflammation and thrombosis in cardiovascular pathology	326
Evaluation and management of heart failure with preserved ejection fraction	321
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia	321
Smart wearable devices in cardiovascular care: where we are and how to move forward	305
PPAR control of metabolism and cardiovascular functions	285
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management	284
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation	279
Global epidemiology of dyslipidaemias	275
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases	268
Cardiac natriuretic peptides	253
Pathophysiology of sepsis-induced cardiomyopathy	227
Native and bioengineered extracellular vesicles for cardiovascular therapeutics	220
Epidemiology of cardiovascular disease in Europe	219
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease	217
Global epidemiology of valvular heart disease	207
Transportation noise pollution and cardiovascular disease	204
Self-powered cardiovascular electronic devices and systems	198

Cellular and molecular pathobiology of heart failure with preserved ejection fraction	186
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6	177
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium	172
Single-cell RNA sequencing in cardiovascular development, disease and medicine	167
Cardiovascular effects and safety of (non-aspirin) NSAIDs	165
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis	164
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms	161
Ceramides and other sphingolipids as drivers of cardiovascular disease	154
Cardiovascular disease in patients with severe mental illness	150
Heart failure with mid-range or mildly reduced ejection fraction	147
Epicardial adipose tissue in contemporary cardiology	146
Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes	141
The role of cardiac rehabilitation in improving cardiovascular outcomes	140
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment	138
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging	135
Systems biology in cardiovascular disease: a multiomics approach	134
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity	124
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches	123
Lifestyle interventions for the prevention and treatment of hypertension	121
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?	115
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy	113
Epidemiology of the inherited cardiomyopathies	112
Sit less and move more for cardiovascular health: emerging insights and opportunities	111
Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management	111
Optical coherence tomography in coronary atherosclerosis assessment and intervention	104
Pregnancy and cardiovascular disease	103
Vascular toxic effects of cancer therapies	98
Genomics of hypertension: the road to precision medicine	97
Cardiac optogenetics: a decade of enlightenment	95
Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target	95
High-density lipoproteins, reverse cholesterol transport and atherogenesis	88
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development	85
Apolipoproteins in vascular biology and atherosclerotic disease	84
Genomic frontiers in congenital heart disease	82
The role of cellular senescence in cardiac disease: basic biology and clinical relevance	81
Catheter ablation for atrial fibrillation: current indications and evolving technologies	81
Transforming growth factor-β in myocardial disease	80
Blood pressure and its variability: classic and novel measurement techniques	80
Complete versus incomplete coronary revascularization: definitions, assessment and outcomes	78
Device-based therapies for arterial hypertension	76
Cardiovascular risks of climate change	73
Applications of artificial intelligence in cardiovascular imaging	72
Climate change and cardiovascular disease: implications for global health	70
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19	70
Cardiac involvement in the long-term implications of COVID-19	70